HopeStage
Back to all studies
RecruitingNCT05770375

Safety and tolerability of MDMA in people with schizophrenia

About this titleRead the official source — NCT05770375
Medication studyAges 18–60United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Listed locations
Los AngelesSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
Anya Bershad, MD, PhD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT05770375
Official title
Show the full official title

Tolerability of MDMA in Schizophrenia

Recruitment & locations

Currently recruiting

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Anya Bershad, MD, PhD.

Does this study involve medication?

Yes. The study involves medication, including MDMA 40mg, MDMA 80mg and MDMA 120mg.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies